Torna all'elenco degli studi

A Study to Evaluate CC-92480 in Combination With Carfilzomib and Dexamethasone (480Kd) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

CODICE STUDIO

NCT05552976

TIPOLOGIA

Ricaduti

NOME SPONSOR

Bristol-Myers Squibb

DESCRIZIONE

Trattamento

Experimental: 480Kd (CC-92480 + Carfilzomib + Dexamethasone)

  • Drug: CC-92480Specified dose on specified daysOther Names:
    • BMS-986348
    • Mezigdomide
  • Drug: CarfilzomibSpecified dose on specified daysOther Name: Kyprolis
  • Drug: DexamethasoneSpecified dose on specified daysOther Names:
    • Decadron
    • Dex

Active Comparator: Kd (Carfilzomib + Dexamethasone)

  • Drug: CarfilzomibSpecified dose on specified daysOther Name: Kyprolis
  • Drug: DexamethasoneSpecified dose on specified daysOther Names:
    • Decadron
    • Dex
Leggi tutto

FARMACI UTILIZZATI

Carfilzomib, Desametasone, CC-92480 ( Mezigdomide)